StonvexLoading…
StonvexStonvexStonvexCore line items from EGAN's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Annual 2025 2025-06-30 | Annual 2024 2024-06-30 | Annual 2024 2024-03-31 | Annual 2023 2023-12-31 |
|---|---|---|---|---|
Revenue | $88.43M | $92.80M | $22.35M | $23.82M |
Operating Income | $4.43M | $5.97M | $938.00K | $2.42M |
Net Income | $32.25M | $7.78M | $1.49M | $2.19M |
EPS (Diluted) | $1.13 | $0.25 | $0.05 | $0.07 |
Total Assets | $148.00M | $127.85M | Not available | Not available |
Total Liabilities | $67.27M | $69.36M | Not available | Not available |
Cash & Equivalents | $62.91M | $70.00M | Not available | Not available |
Free Cash Flow OCF − CapEx | $4.70M | $12.26M | Not available | Not available |
Shares Outstanding | 27.08M | 29.16M | Not available | Not available |